upfront egfr-targeted therapy
Published 8 years ago • 141 plays • Length 8:28Download video MP4
Download video MP3
Similar videos
-
4:41
upfront egfr-targeted therapy for nsclc
-
3:48
mechanisms of resistance to upfront egfr-targeted therapy
-
5:10
sequencing egfr-targeted therapies in nsclc
-
5:09
egfr therapy as upfront colorectal cancer treatment
-
41:23
multimodal management of early-stage nsclc: egfr-targeted therapy in perioperative settings
-
5:00
options for up-front therapy in egfr-mutant nsclc
-
7:10
upfront egfr therapy in metastatic colorectal cancer
-
5:47
egfr tkis for upfront treatment of nsclc
-
1:06
dr. goldman on targeted therapy options for egfr-, alk-, and ros1-mutated nsclc
-
5:07
how is molecular testing used to select upfront therapy in patients with egfr mutations?
-
8:27
egfr-targeted therapy for squamous ncslc
-
0:54
dr. scagliotti on egfr targeted therapy survival benefits
-
1:00
dr. villaruz on egfr-targeted therapies in nsclc
-
13:46
choosing between vegf and egfr targeted therapy in mcrc
-
20:24
targeted treatment with egfr tkis: front line options
-
59:19
precision oncology in early-stage lung cancer, with adjuvant egfr-targeted therapy leading the way
-
5:50
targeted therapy in egfr exon 20-mutant non–small cell lung cancer
-
16:30
up-front treatment in egfr wild-type patients
-
1:56
what targeted therapies are used for people with the egfr mutation?